Nonspecific membrane bilayer perturbations by ivermectin underlie SARS-CoV-2 in vitro activity
R. T. Eastman, R. Rusinova, K. F. Herold, X.-P. Huang, P. Dranchak, T. C. Voss, S. Rana, J. H. Shrimp, A. D. White, H. C. Hemmings, B. L. Roth, J. Inglese, O. S. Andersen, J. L. Dahlin
This study shows ivermectin reduces SARS-CoV-2 viral burden in vitro but at concentrations that also cause cytotoxicity, suggesting its antiviral effect may be due to nonspecific membrane perturbation rather than specific antiviral activity.
bioRxiv · Oct 23, 2023 · PreprintPharmacology & Toxicology